Controlled clinical trials of cell therapy in stroke: Meta-analysis at six months after treatment

Abstract

Background

Cell therapy is promising in experimental studies and has been assessed only in a few studies on humans.

Aims

To evaluate the effect of cell therapy in humans.

Methods

We included clinical trials with a control group that reported safety and efficacy six months following treatment. Quality was evaluated and clinical scales data were extracted. Quantitative analysis was based on the standardized means difference (SMD). Among 28 trials published from 1995 to 2016, nine studies (194 patients; 191 controls) were eligible. Publication biases were assessed with the funnel plot and pre-specified explanatory variables were tested with a group analysis and a meta-regression.

Results

The overall quality was moderate. Cell therapy had a positive effect on the outcome (SMD: 0.57, 95% CI: 0.22–0.92; p = 0.002). The sensitivity analysis showed an upper level of effect size of 0.81 (95% CI: 0.34–1.27; p = 0.001) and a lower level of 0.455 (95% CI: 0.04–0.87; p = 0.03). None of the pre-specified explanatory variable was significantly correlated to outcome: age, ratio infarction/hemorrhage, delay from stroke to treatment, route of administration, cell type, randomization, and blinded outcome assessment. The significant heterogeneity (p = 0.03) was not explained by publication biases (p = 0.09) and was more likely due to methodological and quality differences between the trials.

Conclusions

This result suggests that cell therapy is beneficial in stroke and is expected to help in the designing of stem cells controlled clinical trials (CCT) in large populations.

Keywords

Clinical trial intracerebral hemorrahage ischemic stroke stem cells therapy recovery

Get full access to this article

View all access options for this article.

References

Jauch

Saver

Adams

Jr et al.

Guidelines for the early management of patients with acute ischemic stroke: a guideline for healthcare professionals from the american heart association/american stroke association. Stroke 2013; 44: 870–947.

Balami

Sutherland

Edmunds

et al.

A systematic review and meta-analysis of randomized controlled trials of endovascular thrombectomy compared with best medical treatment for acute ischemic stroke. Int J Stroke 2015; 10: 1168–1178.

Jin

Wang

Xie

et al.

Evidence for stroke-induced neurogenesis in the human brain. Proc Natl Acad Sci USA 2006; 103: 13198–13202.

Favre

Zeffiro

Detante

Krainik

Hommel

Jaillard

. Upper limb recovery after stroke is associated with ipsilesional primary motor cortical activity: a meta-analysis. Stroke 2014; 45: 1077–1083.

Murphy

Corbett

. Plasticity during stroke recovery: from synapse to behaviour. Nat Rev Neurosci 2009; 10: 861–872.

Parent

Vexler

Gong

Derugin

Ferriero

. Rat forebrain neurogenesis and striatal neuron replacement after focal stroke. Ann Neurol 2002; 52: 802–813.

Walker

Patel

Stappenbeck

. The stem cell niche. J Pathol 2009; 217: 169–180.

Detante

Jaillard

Moisan

et al.

Biotherapies in stroke. Rev Neurol 2014; 170: 779–798.

Lees

Sena

Egan

et al.

Stem cell-based therapy for experimental stroke: a systematic review and meta-analysis. Int J Stroke 2012; 7: 582–588.

10.

Jeong

Yim

Cho

et al.

Efficacy and safety of stem cell therapies for patients with stroke: a systematic review and single arm meta-analysis. Int J Stem Cells 2014; 7: 63–69.

11.

Wang

Duan

Wang

Liu

. Effect of stem cell-based therapy for ischemic stroke treatment: a meta-analysis. Clin Neurol Neurosurg 2016; 146: 1–11.

12.

Bang

Lee

. Autologous mesenchymal stem cell transplantation in stroke patients. Ann Neurol 2005; 57: 874–882.

13.

Rabinovitch

Seledtsov

Banul

et al.

Cell therapy of brain stroke. Cell Tech Biol Med 2005; 1: 126–128.

14.

Kondziolka

Steinberg

Wechsler

et al.

Neurotransplantation for patients with subcortical motor stroke: a phase 2 randomized trial. J Neurosurg 2005; 103: 38–45.

15.

Bhasin

Srivastava

Kumaran

et al.

Autologous mesenchymal stem cells in chronic stroke. Cerebrovasc Dis Extra 2011; 1: 93–104.

16.

Moniche

Gonzalez

Gonzalez-Marcos

et al.

Intra-arterial bone marrow mononuclear cells in ischemic stroke: a pilot clinical trial. Stroke 2012; 43: 2242–2244.

17.

Bhasin

Srivastava

Mohanty

Bhatia

Kumaran

Bose

. Stem cell therapy: a clinical trial of stroke. Clin Neurol Neurosurg 2013; 115: 1003–1008.

18.

Zhang

Guo

et al.

Autologous bone marrow mononuclear cell implantation for intracerebral hemorrhage-a prospective clinical observation. Clin Neurol Neurosurg 2013; 115: 72–76.

19.

Chen

Lin

Fan

et al.

Intracerebral implantation of autologous peripheral blood stem cells in stroke patients: a randomized phase ii study. Cell Transplant 2014; 23: 1599–1612.

20.

Prasad

Sharma

Garg

et al.

Intravenous autologous bone marrow mononuclear stem cell therapy for ischemic stroke: a multicentric, randomized trial. Stroke 2014; 45: 3618–3624.

21.

Langhorne

Bernhardt

Kwakkel

. Stroke rehabilitation. Lancet 2011; 377: 1693–1702.

Supplementary Material

Please find the following supplemental material available below.

For Open Access articles published under a Creative Commons License, all supplemental material carries the same license as the article it is associated with.

For non-Open Access articles published, all supplemental material carries a non-exclusive license, and permission requests for re-use of supplemental material or any part of supplemental material shall be sent directly to the copyright owner as specified in the copyright notice associated with the article.

0.00 MB

0.58 MB